Not Medicare Enrolled

Dr. Khaled Jreisat, MD

Optician · Wilmington, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3806 PEACHTREE AVE, Wilmington, NC 28403
9103994197
In practice since 2006 (19 years)
NPI: 1396843132 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jreisat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jreisat? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jreisat

Dr. Khaled Jreisat is an optician specialist in Wilmington, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Jreisat performed 131 Medicare services across 112 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jreisat received a total of $15,793 from 75 pharmaceutical and/or device companies across 1125 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jreisat is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 131 Medicare services $15,793 industry payments

Medicare Practice Summary

Medicare Utilization ↗
131
Medicare services
Bottom 13% in NC for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
112
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
52 $58 $205
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
37 $49 $250
New patient office visit, complex (60-74 min) 30 $119 $330
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $54 $145
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2023 ↗
$15,793
Total received (2018-2023)
Avg $2,632/year across 6 years
Top 9% in NC for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
1,125
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,910 (94.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$883 (5.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$472
2022
$3,421
2021
$3,560
2020
$3,114
2019
$2,828
2018
$2,398

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Harmony Biosciences LLC
$70
Sumitomo Pharma America, Inc.
$67
IMPEL PHARMACEUTICALS INC.
$45
Avion Pharmaceuticals
$41
Eisai Inc.
$40
IDORSIA PHARMACEUTICALS US INC
$36
Lilly USA, LLC
$30
Azurity Pharmaceuticals, Inc.
$19
UCB, Inc.
$18
Kyowa Kirin, Inc.
$17
Corium, LLC
$16
Genentech USA, Inc.
$16
Teva Pharmaceuticals USA, Inc.
$15
Neurocrine Biosciences, Inc.
$14
JAZZ PHARMACEUTICALS INC.
$14
Novartis Pharmaceuticals Corporation
$14
Top 3 companies account for 38.5% of 2023 payments
All-time payments by company (2018-2023) ›
Novartis Pharmaceuticals Corporation
$1,266
UCB, Inc.
$1,195
Teva Pharmaceuticals USA, Inc.
$1,163
Sunovion Pharmaceuticals Inc.
$867
Amgen Inc.
$833
Supernus Pharmaceuticals, Inc.
$755
GENZYME CORPORATION
$531
EMD Serono, Inc.
$427
Genentech USA, Inc.
$421
Harmony Biosciences LLC
$402
Acorda Therapeutics, Inc
$395
Adamas Pharmaceuticals, Inc.
$375
LivaNova USA, Inc.
$365
Eisai Inc.
$361
JAZZ PHARMACEUTICALS INC.
$351
SK Life Science, Inc.
$322
Lundbeck LLC
$305
Avanir Pharmaceuticals, Inc.
$302
EISAI INC.
$284
Upsher-Smith Laboratories LLC
$233
Biohaven Pharmaceuticals, Inc.
$231
AQUESTIVE THERAPEUTICS, INC.
$228
Neurocrine Biosciences, Inc.
$224
Biogen, Inc.
$220
Mallinckrodt Hospital Products Inc.
$205
Avion Pharmaceuticals
$205
Janssen Pharmaceuticals, Inc
$189
Lilly USA, LLC
$183
MDD US Operations, LLC
$159
Kyowa Kirin, Inc.
$157
AbbVie Inc.
$153
Allergan, Inc.
$147
Alexion Pharmaceuticals, Inc.
$144
ABBVIE INC.
$144
Allergan Inc.
$143
Biohaven Pharmaceutical Holding Company Ltd.
$140
ARBOR PHARMACEUTICALS, INC.
$137
Neurelis, Inc.
$133
Egalet US Inc
$119
Jazz Pharmaceuticals Inc.
$110
Amneal Pharmaceuticals LLC
$109
IDORSIA PHARMACEUTICALS US INC
$95
Arbor Pharmaceuticals, Inc.
$86
Currax Pharmaceuticals LLC
$77
US WorldMeds, LLC
$70
Sumitomo Pharma America, Inc.
$67
Greenwich Biosciences, Inc.
$55
Promius Pharma LLC
$52
E.R. Squibb & Sons, L.L.C.
$45
Aprecia Pharmaceuticals, LLC
$45
IMPEL PHARMACEUTICALS INC.
$45
Exeltis, USA Inc.
$43
HARMONY BIOSCIENCES LLC
$43
Axsome Therapeutics, Inc.
$35
SANOFI-AVENTIS U.S. LLC
$30
Mitsubishi Tanabe Pharma America, Inc.
$25
Assertio Therapeutics, Inc.
$25
Impax Laboratories, Inc.
$25
Mallinckrodt LLC
$25
Bayer HealthCare Pharmaceuticals Inc.
$25
Shire North American Group Inc
$23
Merck Sharp & Dohme Corporation
$23
Medtronic, Inc.
$22
Azurity Pharmaceuticals, Inc.
$19
ARGENX US, INC.
$18
Celgene Corporation
$16
Corium, LLC
$16
Cala Health, Inc.
$15
MITSUBISHI TANABE PHARMA AMERICA, INC.
$15
ASSERTIO THERAPEUTICS, Inc.
$13
Mallinckrodt Enterprises LLC
$13
Neos Therapeutics, LP
$13
Zyla Life Sciences
$13
ACADIA Pharmaceuticals Inc
$12
BioMarin Pharmaceutical Inc.
$11
Top 3 companies account for 23.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Adzenys XR-ODT · Aimovig · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Betaseron · Brineura · Briviact · CALA TRIO · CONTRAVE · COPAXONE · Cambia · Dayvigo · Dhivy · EMGALITY · EPIDIOLEX · Epidiolex · Eprontia · Fintepla · Fycompa · GILENYA · GOCOVRI · Gralise · Horizant · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · KYNMOBI · LEMTRADA · MAYZENT · MYDAYIS · MYOBLOC · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · ONFI · ONGENTYS · OXTELLAR XR · Ocrevus · Ongentys · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RADICAVA · RYTARY · Radicava · Rebif · SOLIRIS · SPRIX · SUNOSI · SYMPAZAN · Soliris · Spritam · Sunosi · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · Vimpat · WAKIX · Wakix · XCOPRI · XYREM · XYWAV · Xadago · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for optician in NC.

Looking for an optician specialist in Wilmington?
Compare opticians in the Wilmington area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
39
Per 100K population
16.9
County median income
$72,892
Nearest hospital
WILMINGTON TREATMENT CENTER
7.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Jreisat is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 9% of NC peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Jreisat experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Jreisat performed 52 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jreisat receive payments from pharmaceutical companies?
Yes. Dr. Jreisat received a total of $15,793 from 75 companies across 1,125 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jreisat's costs compare to other opticians in Wilmington?
Dr. Jreisat's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Jreisat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →